Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation.

Coproduction Equity Guidance Guidelines Integrated knowledge translation Stakeholder engagement Systematic reviews

Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 06 08 2019
accepted: 06 01 2020
entrez: 3 2 2020
pubmed: 3 2 2020
medline: 26 1 2021
Statut: epublish

Résumé

Stakeholder engagement has become widely accepted as a necessary component of guideline development and implementation. While frameworks for developing guidelines express the need for those potentially affected by guideline recommendations to be involved in their development, there is a lack of consensus on how this should be done in practice. Further, there is a lack of guidance on how to equitably and meaningfully engage multiple stakeholders. We aim to develop guidance for the meaningful and equitable engagement of multiple stakeholders in guideline development and implementation. This will be a multi-stage project. The first stage is to conduct a series of four systematic reviews. These will (1) describe existing guidance and methods for stakeholder engagement in guideline development and implementation, (2) characterize barriers and facilitators to stakeholder engagement in guideline development and implementation, (3) explore the impact of stakeholder engagement on guideline development and implementation, and (4) identify issues related to conflicts of interest when engaging multiple stakeholders in guideline development and implementation. We will collaborate with our multiple and diverse stakeholders to develop guidance for multi-stakeholder engagement in guideline development and implementation. We will use the results of the systematic reviews to develop a candidate list of draft guidance recommendations and will seek broad feedback on the draft guidance via an online survey of guideline developers and external stakeholders. An invited group of representatives from all stakeholder groups will discuss the results of the survey at a consensus meeting which will inform the development of the final guidance papers. Our overall goal is to improve the development of guidelines through meaningful and equitable multi-stakeholder engagement, and subsequently to improve health outcomes and reduce inequities in health.

Sections du résumé

BACKGROUND
Stakeholder engagement has become widely accepted as a necessary component of guideline development and implementation. While frameworks for developing guidelines express the need for those potentially affected by guideline recommendations to be involved in their development, there is a lack of consensus on how this should be done in practice. Further, there is a lack of guidance on how to equitably and meaningfully engage multiple stakeholders. We aim to develop guidance for the meaningful and equitable engagement of multiple stakeholders in guideline development and implementation.
METHODS
This will be a multi-stage project. The first stage is to conduct a series of four systematic reviews. These will (1) describe existing guidance and methods for stakeholder engagement in guideline development and implementation, (2) characterize barriers and facilitators to stakeholder engagement in guideline development and implementation, (3) explore the impact of stakeholder engagement on guideline development and implementation, and (4) identify issues related to conflicts of interest when engaging multiple stakeholders in guideline development and implementation.
DISCUSSION
We will collaborate with our multiple and diverse stakeholders to develop guidance for multi-stakeholder engagement in guideline development and implementation. We will use the results of the systematic reviews to develop a candidate list of draft guidance recommendations and will seek broad feedback on the draft guidance via an online survey of guideline developers and external stakeholders. An invited group of representatives from all stakeholder groups will discuss the results of the survey at a consensus meeting which will inform the development of the final guidance papers. Our overall goal is to improve the development of guidelines through meaningful and equitable multi-stakeholder engagement, and subsequently to improve health outcomes and reduce inequities in health.

Identifiants

pubmed: 32007104
doi: 10.1186/s13643-020-1272-5
pii: 10.1186/s13643-020-1272-5
pmc: PMC6995157
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21

Subventions

Organisme : Medical Research Council
ID : MRC_UU_12017/15
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC_UU_12017/13
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU15
Pays : United Kingdom
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : CIHR
ID : FDN 143237
Pays : Canada
Organisme : CIHR
ID : PJT-155970
Pays : Canada
Organisme : Chief Scientist Office
ID : SPHSU13
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU17
Pays : United Kingdom

Références

J Comp Eff Res. 2015 Mar;4(2):133-45
pubmed: 25825842
BMJ Open. 2014 Dec 05;4(12):e005660
pubmed: 25479795
Syst Rev. 2018 Nov 24;7(1):208
pubmed: 30474560
Qual Health Care. 1999 Sep;8(3):177-83
pubmed: 10847875
Gastrointest Endosc. 2015 Mar;81(3):489-501.e26
pubmed: 25708752
J Clin Epidemiol. 2017 Aug;88:102-112
pubmed: 28579379
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
Health Care Manage Rev. 1998 Summer;23(3):30-7
pubmed: 9702559
Implement Sci. 2012 Jul 23;7:67
pubmed: 22824094
J Clin Epidemiol. 2017 Oct;90:68-75
pubmed: 28499847
Eur Respir J. 2017 Mar 22;49(3):
pubmed: 28331043
J Clin Epidemiol. 2017 Jul;87:4-13
pubmed: 28529184
Health Res Policy Syst. 2006 Nov 21;4:13
pubmed: 17118181
Implement Sci. 2016 Sep 20;11(1):126
pubmed: 27647000
Bull World Health Organ. 2006 Aug;84(8):643-51
pubmed: 16917652
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Int J Qual Health Care. 2016 Feb;28(1):122-8
pubmed: 26796486
Med J Aust. 2015 Oct 5;203(7):283-4
pubmed: 26424059
Am J Public Health. 2010 Apr 1;100 Suppl 1:S40-6
pubmed: 20147663
J Gen Intern Med. 2019 Mar;34(3):458-463
pubmed: 30565151
J Health Serv Res Policy. 2019 Oct;24(4):245-255
pubmed: 30997859
Health Expect. 2015 Oct;18(5):942-55
pubmed: 23634973
J Clin Epidemiol. 2014 Jan;67(1):56-64
pubmed: 24189091
Res Involv Engagem. 2017 Aug 2;3:13
pubmed: 29062538
Implement Sci. 2008 Dec 17;3:54
pubmed: 19091108
Qual Health Res. 2012 Aug;22(8):1126-37
pubmed: 22673090
F1000Res. 2018 Jun 18;7:752
pubmed: 30364075
BMJ. 2017 Jan 16;356:j80
pubmed: 28093384
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
PLoS One. 2015 Apr 07;10(4):e0122246
pubmed: 25849568
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
Health Expect. 2017 Feb;20(1):3-10
pubmed: 27115476
Res Involv Engagem. 2018 Oct 22;4:34
pubmed: 30377540
Health Expect. 2008 Mar;11(1):72-84
pubmed: 18275404
Proc Am Thorac Soc. 2012 Dec;9(5):269-73
pubmed: 23256170
Health Res Policy Syst. 2014 Jul 14;12:34
pubmed: 25023520
Res Involv Engagem. 2017 Oct 2;3:19
pubmed: 29062544
J Multidiscip Healthc. 2015 Feb 16;8:101-8
pubmed: 25733912
Bull World Health Organ. 2017 Feb 1;95(2):87
pubmed: 28250505
World Allergy Organ J. 2015 Jan 27;8(1):4
pubmed: 25628773
J Gen Intern Med. 2012 Aug;27(8):985-91
pubmed: 22528615
Int J Health Serv. 1992;22(3):429-45
pubmed: 1644507

Auteurs

Jennifer Petkovic (J)

Bruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose Ave East, Ottawa, Ontario, Canada. jennifer.petkovic@uottawa.ca.

Alison Riddle (A)

Bruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose Ave East, Ottawa, Ontario, Canada.

Elie A Akl (EA)

Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.

Joanne Khabsa (J)

Clinical Research Institute, American University of Beirut, Beirut, Lebanon.

Lyubov Lytvyn (L)

McMaster University, Hamilton, Ontario, Canada.

Pearl Atwere (P)

Bruyère Research Institute, 85 Primrose Ave East, Ottawa, Ontario, Canada.

Pauline Campbell (P)

Nursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.

Kalipso Chalkidou (K)

Faculty of Medicine, School of Public Health Imperial College, London, UK.

Stephanie M Chang (SM)

Agency for Healthcare Research and Quality, Rockville, MD, USA.

Sally Crowe (S)

Crowe Associates Ltd., Oxford, UK.

Leonila Dans (L)

Department of Clinical Epidemiology, University of the Philippines-Manila, Taft Ave, 1000, Manila, Philippines.

Fadi El Jardali (FE)

American University of Beirut, Beirut, Lebanon.

Davina Ghersi (D)

National Health and Medical Research Council, Canberra, Australia.

Ian D Graham (ID)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Sean Grant (S)

Department of Social & Behavioral Sciences, Richard M. Fairbanks School of Public Health, Indiana University, 1050 Wishard Blvd, RG 6046, Indianapolis, IN, 46202, USA.

Regina Greer-Smith (R)

LLC/S.T.A.R. Initiative, Apple Valley, CA, USA.

Jeanne-Marie Guise (JM)

Departments of Obstetrics and Gynecology, Medical Informatics & Clinical Epidemiology, Emergency Medicine Oregon Health & Science, University School of Medicine and the OHSU-PSU School of Public Health, Portland, USA.

Glen Hazlewood (G)

University of Calgary, Calgary, Canada.

Janet Jull (J)

School of Rehabilitation Therapy, Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.

S Vittal Katikireddi (SV)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow, G2 3AX, UK.

Etienne V Langlois (EV)

Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.

Anne Lyddiatt (A)

Cochrane Musculoskeletal Group, London, Ontario, Canada.

Lara Maxwell (L)

University of Ottawa, Ottawa, Canada.

Richard Morley (R)

The Cochrane Collaboration, Cochrane Consumer Network, London, UK.

Reem A Mustafa (RA)

Department of Internal Medicine/Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas, USA.

Francesco Nonino (F)

Unit of Epidemiology and Statistics, IRCCS - Institute of Neurological Sciences of Bologna, Bologna, Italy.

Jordi Pardo Pardo (JP)

Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.

Alex Pollock (A)

Nursing Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.

Kevin Pottie (K)

Departments of Family Medicine and Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
Primary Care Research Group and Equity Methods Group, Bruyère Research Institute, Ottawa, Canada.

John Riva (J)

Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.

Holger Schünemann (H)

Department of Health Research Methods, Evidence, and Impact, Cochrane Canada and McMaster GRADE Centre, Hamilton, Canada.

Rosiane Simeon (R)

Bruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose Ave East, Ottawa, Ontario, Canada.

Maureen Smith (M)

Cochrane Consumer Executive, Ottawa, Ontario, Canada.

Airton T Stein (AT)

Programa de Pós-Graduação em Ciências da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil.

Anneliese Synnot (A)

Centre for Health Communication and Participation, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
Cochrane Australia, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Janice Tufte (J)

PCORI, Seattle, USA.

Howard White (H)

Alfred Deakin University, Geelong, Australia.
Journal of Development Studies and Journal of Development Effectiveness, Geelong, Victoria, Australia.

Vivian Welch (V)

Bruyère Research Institute, Bruyère Continuing Care and University of Ottawa, 85 Primrose Ave East, Ottawa, Ontario, Canada.
The Campbell Collaboration, Oslo, Norway.

Thomas W Concannon (TW)

The RAND Corporation, Boston, MA, USA.
Tufts Clinical & Translational Science Institute, Tufts University School of Medicine, Boston, MA, USA.

Peter Tugwell (P)

University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa, Canada.
Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada.
University of Ottawa, School of Epidemiology and Public Health, Faculty of Medicine, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH